Serum testosterone and short-term mortality in men with acute myocardial infarction

Constantin Militaru1, Ionut Donoiu, Ovidiu Dracea

  • 1Craiova Cardiology Center, Romania.

Cardiology Journal
|June 11, 2010
PubMed

Insights

Low testosterone levels in men with acute myocardial infarction are linked to higher short-term mortality. This study investigated the association between serum testosterone and 30-day mortality in these patients.

Area of Science:

  • Cardiology
  • Endocrinology
  • Men's Health

Background:

  • Previous studies suggest an inverse relationship between testosterone levels and cardiovascular mortality in men.
  • However, large prospective studies have not confirmed a significant association between testosterone and coronary events.

Purpose of the Study:

  • To investigate the relationship between serum testosterone levels and short-term (30-day) mortality in male patients diagnosed with acute myocardial infarction.

Main Methods:

  • 126 male patients admitted with acute myocardial infarction were included.
  • Serum free testosterone (T) levels were measured at admission using a chemiluminescence assay.
  • 30-day mortality was analyzed along with other biomarkers like hs-CRP, NT-proBNP, and HbA1c.

Main Results:

  • The mean serum T level was 4.1 +/- 2.9 ng/mL.
  • All patients who did not survive the 30-day period had a T level of less than or equal to 3 ng/mL.
  • A low serum T level was found to be independently associated with total short-term mortality.

Conclusions:

  • Low serum testosterone levels are independently associated with increased short-term mortality in men with acute myocardial infarction.
  • Testosterone levels may serve as a prognostic marker for short-term outcomes in male myocardial infarction patients.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...